tirzepatide vs semaglutide trial Tops for Weight Loss in Head-to-Head Trial, Eli Lilly Says SURPASS-2 (NEJM 2021) was the

In this context, targeting QA, or the enzymatic steps that govern the balance of KP metabolites, may represent a more tractable therapeutic strategy, allowing attenuation of NMDAR-driven excitotoxicity without disrupting 7nAChR-dependent cognitive processes

Xu, G.Y., M.G

Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals

Batista JA, de Aguiar Magalhes D, Sousa SG, dos Santos FJ, Pereira CM, do Nascimento Lima JV, de Albuquerque IF, Bezerra NL, de Brito TV, da Silva Monteiro CE, Franco AX

Brand names, logos, and trademarks used herein remain the property of their respective owners